Targeted deep learning classification and feature extraction for clinical diagnosis.

Area of Science:

• Biochemistry and Bioinformatics
• Computational Biology
• Machine Learning in Medicine

Background:

• Protein biomarkers are crucial for classifying disease states, aiding in understanding metabolic or immunodeficient conditions.
• Machine learning (ML) shows promise in biomarker discovery but existing frameworks often lack broad applicability across different diseases.
• Current ML approaches may not effectively handle the complexity and diversity of patient symptom classes.

Purpose of the Study:

• To develop a versatile feature extractor capable of discovering protein biomarkers for a wide range of classification tasks.
• To improve upon the limitations of existing ML frameworks that are often disease-specific.
• To enhance the accuracy and reliability of biomarker identification for clinical applications.

Main Methods:

• Utilized a specialized deep learning model to create a latent space for optimal class separation and cluster identity.
• Developed a novel feature extractor designed for broad applicability in biomarker discovery.
• Applied the developed methods to independent datasets from COVID-19 and scleroderma patients.

Main Results:

• Demonstrated improved class separation in patient data compared to traditional models.
• Achieved reduced false discovery rates, indicating higher precision in biomarker identification.
• Validated the feature extractor's effectiveness on distinct disease datasets (COVID-19 and scleroderma).

Conclusions:

• The proposed deep learning feature extractor offers a robust and broadly applicable method for protein biomarker discovery.
• This approach significantly enhances classification accuracy and reduces errors in disease state characterization.
• The findings suggest a powerful new tool for advancing personalized medicine and diagnostics.